Stacey Chung

FOXC1: an emerging marker and therapeutic target for cancer

A. Giuliano, Y. Qu, X. Cui, 2017, Oncogene.

TOP1 inhibition induces bifurcated JNK/MYC signaling that dictates cancer cell sensitivity

Hisashi Tanaka, A. Giuliano, X. Cui, 2022, International journal of biological sciences.

FOXC1-Induced Non-Canonical WNT5A-MMP7 Signaling Regulates Invasiveness in Triple-Negative Breast Cancer

Hisashi Tanaka, A. Giuliano, Wei Yang, 2017, Oncogene.

Identification of EGF-NF-κB-FOXC1 signaling axis in basal-like breast cancer

A. Giuliano, Y. Qu, X. Cui, 2017, Cell Communication and Signaling.

Characterization of primary human mammary epithelial cells isolated and propagated by conditional reprogrammed cell culture

A. Giuliano, Y. Qu, X. Cui, 2017, Oncotarget.

Hypoxia-activated neuropeptide Y/Y5 receptor/RhoA pathway triggers chromosomal instability and bone metastasis in Ewing sarcoma

Jason U Tilan, Hongkun Wang, C. Albanese, 2022, Nature Communications.

Disabling the Nuclear Translocalization of RelA/NF-κB by a Small Molecule Inhibits Triple-Negative Breast Cancer Growth

R. Murali, M. Greene, X. Cui, 2021, Breast cancer.

Publisher Correction: Hypoxia-activated neuropeptide Y/Y5 receptor/RhoA pathway triggers chromosomal instability and bone metastasis in Ewing sarcoma

Hongkun Wang, A. Cheema, Congyi Lu, 2022, Nature Communications.